Full prescribing information for MYRBETRIQ™ (mirabegron) extended-release tablets, for oral use, indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency

NORTHBROOK, IL USA - Myrbetriq™ is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. Click the image below to view or download FULL PRESCRIBING INFORMATION.

myrbetriq-full-pi



Revised: June 2012 11G054-MIR

Manufactured by:
Astellas Pharma Technologies, Inc.
Norman, Oklahoma 73072

Marketed and Distributed by:
Astellas Pharma US, Inc.
Northbrook, Illinois 60062

 

© 2012 Astellas Pharma US, Inc.